Skip to content

Effect of Intra-silicon oil Triamcinolone acetonide on macular anatomy in rhegmatogenous retinal detachment

Survey the effect of intra-silicon oil Triamcinolone acetonide on macular anatomy after vitrectomy for rhegmatogenous retinal detachment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200620047837N1
Enrollment
60
Registered
2020-08-08
Start date
2020-06-27
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rhegmatogenous retinal detachment. Retinal detachment with retinal break

Interventions

Intervention 1: Intervention group: Injection of 1 time Triamcinolone acetonide within sclerotmy site by dose of 1 mg/0.05 cc from 40mg ampoule made by Alborz Darou company at end of vitrectomy and si

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 18 year old Rhegmatogenous retinal detachment involving macula Need for vitrectomy surgery and silicon oil injection Less than 1month since symptoms initiation

Exclusion criteria

Exclusion criteria: Aphakia Pseudophakia with previous complicated catatract surgery Any complication during previous occular surgeries Previous scleral buckling surgery, pneumatic surgery and vitrectomy surgery Diabetic retinopathy Axial length more than 26 mm or less than 20 mm Abnormal optic disk Need to retinotomy History of uveitis Glucoma or IOP more than 21 mm Hg before operation Abnormal retina such as coloboma and choroidal detachment Tractional retinal detachment Vitreous hemorrhage History of anti-VEGF injection

Design outcomes

Primary

MeasureTime frame
Macular thickness. Timepoint: Before operatio; 1, 3 and 6 months after operation. Method of measurement: Macular OCT with Heidelberg.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad hosein Nowroozzadeh, MD

Shiraz University of Medical Sciences

Nowroozzadeh@hotmail.com+98 71 3629 1470

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026